The table below shows Atara Biotherapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$516.00K
$3.45M
$17.57M
$98.15M
$40.19M
$28.64M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$164.00K
$2.92M
$7.31M
$27.43M
$43.92M
$33.33M
SG&A
ATRA annual revenue (10-K history)
Atara Biotherapeutics, Inc. reported annual revenue of $120.77M for fiscal year 2025. That is down 6.3% from $128.94M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.